In the rapidly evolving field of medical diagnostics, accurate and efficient coding is essential for proper billing and reimbursement. One such critical code is CPT Code 87811, which pertains to rapid influenza diagnostic tests (RIDTs) using immunoassays. Given the increasing demand for quick and reliable flu testing—especially during seasonal outbreaks—understanding this code is crucial for healthcare providers, billing specialists, and laboratory professionals.
This article provides an in-depth exploration of CPT Code 87811, covering its definition, usage, modifiers, procedural aspects, and reimbursement rates. Whether you’re a medical coder, physician, or lab technician, this guide will help you navigate the complexities of this essential diagnostic code.
CPT Code 87811
What Is CPT Code 87811?
CPT Code 87811 is a Current Procedural Terminology (CPT) code used to describe rapid influenza virus antigen detection tests performed using immunoassay techniques. These tests are designed to quickly identify the presence of influenza A and B viruses in respiratory specimens, providing results in as little as 15–30 minutes.
Key Features of CPT Code 87811
-
Test Type: Immunoassay-based rapid influenza diagnostic test (RIDT)
-
Specimen Types: Nasopharyngeal swabs, nasal washes, or aspirates
-
Turnaround Time: Results typically available within 30 minutes
-
Common Use Cases: Emergency departments, urgent care centers, and outpatient clinics
Why Is This Code Important?
-
Speedy Diagnosis: Helps in immediate clinical decision-making for antiviral treatment.
-
Infection Control: Rapid identification aids in preventing outbreaks in hospitals and long-term care facilities.
-
Billing Accuracy: Ensures proper reimbursement for healthcare providers.
Does CPT Code 87811 Need a Modifier?
Modifiers are used to provide additional information about a procedure without changing the definition of the code itself. While CPT Code 87811 does not always require a modifier, certain scenarios may necessitate their use for accurate billing.
Common Modifiers Used with 87811
| Modifier | Description | When to Use |
|---|---|---|
| -QW | CLIA-waived test | Used when the test is performed in a CLIA-waived setting (e.g., physician offices). |
| -59 | Distinct procedural service | Applied if the test is performed separately from other services on the same day. |
| -91 | Repeat clinical diagnostic test | Used if the test is repeated on the same day for confirmation. |
When Are Modifiers Necessary?
-
If the test is performed in a CLIA-waived facility, modifier -QW must be appended.
-
If multiple tests are conducted on the same day, modifier -59 may be required to indicate separate services.
-
Medicare and private insurers may have specific modifier requirements, so always verify payer policies.
What Is Procedure Code 87811?
Procedure Code 87811 refers to the technical and professional components of performing a rapid influenza detection test.
Breakdown of the Procedure
-
Specimen Collection: A nasopharyngeal swab or nasal wash is obtained.
-
Test Processing: The sample is applied to an immunoassay device.
-
Result Interpretation: Visual or automated reading determines influenza A/B presence.
Comparison with Other Flu Test Codes
| CPT Code | Test Type | Methodology | Turnaround Time |
|---|---|---|---|
| 87811 | Rapid Influenza Test | Immunoassay | 15–30 minutes |
| 87633 | Molecular Assay (e.g., PCR) | Nucleic Acid Detection | 1–8 hours |
| 87400 | Influenza Culture | Viral Culture | 3–10 days |
This table highlights why 87811 is preferred for quick decision-making, while molecular tests (e.g., 87633) offer higher accuracy but take longer.
CPT Code 87811 Description
The official AMA CPT manual describes 87811 as:
“Infectious agent antigen detection by immunoassay with direct optical observation; influenza.”
Key Components of the Description
-
Immunoassay-Based: Relies on antibody-antigen binding.
-
Direct Optical Observation: Results are read visually (e.g., color change) or via a small analyzer.
-
Influenza-Specific: Only for influenza A/B, not other respiratory viruses.
Limitations of 87811
-
Lower Sensitivity (50–70%) compared to PCR tests.
-
False Negatives Possible: If viral load is low, confirmatory testing (e.g., PCR) may be needed.
CPT Code 87811 Reimbursement
Reimbursement for 87811 varies by payer (Medicare, Medicaid, private insurers). Below is an estimated breakdown:
2024 Reimbursement Rates (National Average)
| Payer | Approximate Reimbursement |
|---|---|
| Medicare | $25–$35 |
| Medicaid | $20–$30 |
| Private Insurers | $30–$50 |
Factors Affecting Reimbursement
-
Location: CMS adjusts rates based on geographic cost differences.
-
Modifier Use: Incorrect modifiers can lead to claim denials.
-
CLIA Certification: Waived vs. non-waived labs may have different rates.
How to Maximize Reimbursement
✔ Ensure proper documentation of medical necessity.
✔ Use correct modifiers (e.g., -QW for CLIA-waived tests).
✔ Stay updated on annual CPT and payer policy changes.
Conclusion
CPT Code 87811 is essential for rapid influenza detection, offering quick results for timely treatment decisions. Proper use of modifiers, understanding procedural details, and staying informed on reimbursement policies are crucial for accurate billing. While RIDTs have limitations, their speed makes them invaluable during flu season. Always verify payer-specific guidelines to ensure compliance and optimal reimbursement.
FAQs
1. Can CPT Code 87811 be billed with other respiratory tests?
Yes, but modifier -59 may be needed if tests are distinct.
2. Is prior authorization required for 87811?
Most insurers do not require prior authorization, but Medicaid may in some states.
3. What is the difference between 87811 and 87633?
87811 is a rapid antigen test, while 87633 is a molecular (PCR) test with higher accuracy.
4. Does Medicare cover 87811?
Yes, Medicare covers 87811 when medically necessary.
